259 related articles for article (PubMed ID: 23837856)
41. Umbilical cord blood regulatory T-cell expansion and functional effects of tumor necrosis factor receptor family members OX40 and 4-1BB expressed on artificial antigen-presenting cells.
Hippen KL; Harker-Murray P; Porter SB; Merkel SC; Londer A; Taylor DK; Bina M; Panoskaltsis-Mortari A; Rubinstein P; Van Rooijen N; Golovina TN; Suhoski MM; Miller JS; Wagner JE; June CH; Riley JL; Blazar BR
Blood; 2008 Oct; 112(7):2847-57. PubMed ID: 18645038
[TBL] [Abstract][Full Text] [Related]
42. Biomimetic tolerogenic artificial antigen presenting cells for regulatory T cell induction.
Rhodes KR; Meyer RA; Wang J; Tzeng SY; Green JJ
Acta Biomater; 2020 Aug; 112():136-148. PubMed ID: 32522714
[TBL] [Abstract][Full Text] [Related]
43. Beta-2 microglobulin knockout K562 cell-based artificial antigen presenting cells for
Zha S; Li Z; Chen C; Du Z; Tay JC; Wang S
Immunotherapy; 2019 Aug; 11(11):967-982. PubMed ID: 31218907
[No Abstract] [Full Text] [Related]
44. To bead or not to bead.
Dudley ME
J Immunother; 2003; 26(3):187-9. PubMed ID: 12806272
[TBL] [Abstract][Full Text] [Related]
45. Artificial antigen-presenting cells expressing AFP(158-166) peptide and interleukin-15 activate AFP-specific cytotoxic T lymphocytes.
Sun L; Guo H; Jiang R; Lu L; Liu T; Zhang Z; He X
Oncotarget; 2016 Apr; 7(14):17579-90. PubMed ID: 27007051
[TBL] [Abstract][Full Text] [Related]
46. The effect of artificial antigen-presenting cells with preclustered anti-CD28/-CD3/-LFA-1 monoclonal antibodies on the induction of ex vivo expansion of functional human antitumor T cells.
Zappasodi R; Di Nicola M; Carlo-Stella C; Mortarini R; Molla A; Vegetti C; Albani S; Anichini A; Gianni AM
Haematologica; 2008 Oct; 93(10):1523-34. PubMed ID: 18728033
[TBL] [Abstract][Full Text] [Related]
47. HLA tetramer-based artificial antigen-presenting cells for stimulation of CD4+ T cells.
Maus MV; Riley JL; Kwok WW; Nepom GT; June CH
Clin Immunol; 2003 Jan; 106(1):16-22. PubMed ID: 12584046
[TBL] [Abstract][Full Text] [Related]
48. Biodegradable nanoellipsoidal artificial antigen presenting cells for antigen specific T-cell activation.
Meyer RA; Sunshine JC; Perica K; Kosmides AK; Aje K; Schneck JP; Green JJ
Small; 2015 Apr; 11(13):1519-25. PubMed ID: 25641795
[TBL] [Abstract][Full Text] [Related]
49. Co-infusion of CAR T cells with aAPCs expressing chemokines and costimulatory ligands enhances the anti-tumor efficacy in mice.
Li J; Zhou W; Li D; Huang Y; Yang X; Jiang L; Hu X; Yang J; Fu M; Zhang M; Wang F; Li J; Zhang Y; Yang Y; Yan F; Gao H; Wang W
Cancer Lett; 2023 Aug; 568():216287. PubMed ID: 37392990
[TBL] [Abstract][Full Text] [Related]
50. Artificial antigen presenting cell (aAPC) mediated activation and expansion of natural killer T cells.
East JE; Sun W; Webb TJ
J Vis Exp; 2012 Dec; (70):. PubMed ID: 23299308
[TBL] [Abstract][Full Text] [Related]
51. Engineering Nanoscale Artificial Antigen-Presenting Cells by Metabolic Dendritic Cell Labeling to Potentiate Cancer Immunotherapy.
Xiao P; Wang J; Zhao Z; Liu X; Sun X; Wang D; Li Y
Nano Lett; 2021 Mar; 21(5):2094-2103. PubMed ID: 33622034
[TBL] [Abstract][Full Text] [Related]
52. Towards efficient cancer immunotherapy: advances in developing artificial antigen-presenting cells.
Eggermont LJ; Paulis LE; Tel J; Figdor CG
Trends Biotechnol; 2014 Sep; 32(9):456-65. PubMed ID: 24998519
[TBL] [Abstract][Full Text] [Related]
53. Nanoparticles Engineered as Artificial Antigen-Presenting Cells Induce Human CD4
Giang S; Horwitz DA; Bickerton S; La Cava A
Front Immunol; 2021; 12():628059. PubMed ID: 34122401
[TBL] [Abstract][Full Text] [Related]
54. Rapid expansion of cytomegalovirus-specific cytotoxic T lymphocytes by artificial antigen-presenting cells expressing a single HLA allele.
Papanicolaou GA; Latouche JB; Tan C; Dupont J; Stiles J; Pamer EG; Sadelain M
Blood; 2003 Oct; 102(7):2498-505. PubMed ID: 12805061
[TBL] [Abstract][Full Text] [Related]
55. [In vitro cytotoxic effects of CML28 specific T cells on acute leukemia cells].
Mao HW; Liu WL; Zhou JF; Geng Z; Huang W
Zhonghua Xue Ye Xue Za Zhi; 2009 Feb; 30(2):121-4. PubMed ID: 19563024
[TBL] [Abstract][Full Text] [Related]
56. Janus particles as artificial antigen-presenting cells for T cell activation.
Chen B; Jia Y; Gao Y; Sanchez L; Anthony SM; Yu Y
ACS Appl Mater Interfaces; 2014; 6(21):18435-9. PubMed ID: 25343426
[TBL] [Abstract][Full Text] [Related]
57. Artificial Antigen-Presenting Cells for Immunotherapies.
Siefert AL; Fahmy TM; Kim D
Methods Mol Biol; 2017; 1530():343-353. PubMed ID: 28150213
[TBL] [Abstract][Full Text] [Related]
58. DNA origami-based artificial antigen-presenting cells for adoptive T cell therapy.
Sun Y; Sun J; Xiao M; Lai W; Li L; Fan C; Pei H
Sci Adv; 2022 Dec; 8(48):eadd1106. PubMed ID: 36459554
[TBL] [Abstract][Full Text] [Related]
59. Connecting the dots: artificial antigen presenting cell-mediated modulation of natural killer T cells.
Sun W; Subrahmanyam PB; East JE; Webb TJ
J Interferon Cytokine Res; 2012 Nov; 32(11):505-16. PubMed ID: 23050947
[TBL] [Abstract][Full Text] [Related]
60. Investigative and clinical applications of synthetic immune synapses.
Milone MC; Kam LC
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2013; 5(1):75-85. PubMed ID: 22927243
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]